AbbVie (ABBV) jumped higher in its latest intraday trading, supported by ongoing dynamic momentum as the stock continues to trade above its 50-day simple moving average. This comes under the dominance of a primary short-term uptrend, with price action moving along an ascending trendline that reinforces this trajectory. The recent rise followed the stocks successful unwinding of some of its clearly overbought levels on the Relative Strength Indicators, giving it broader room to extend gains in the coming period.

Therefore, we expect the stock to rise in the upcoming trading sessions, as long as the support level of $225.30 remains intact, targeting the key resistance level of $244.80.

Today's price forecast: Bullish